These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7555561

  • 1. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients.
    Clauson PG, Linde B.
    Diabetes Care; 1995 Jul; 18(7):986-91. PubMed ID: 7555561
    [Abstract] [Full Text] [Related]

  • 2. Clinically important differences in insulin absorption from abdomen in IDDM.
    Frid A, Linde B.
    Diabetes Res Clin Pract; 1993 Jul; 21(2-3):137-41. PubMed ID: 8269814
    [Abstract] [Full Text] [Related]

  • 3. Intraregional differences in the absorption of unmodified insulin from the abdominal wall.
    Frid A, Linde B.
    Diabet Med; 1992 Apr; 9(3):236-9. PubMed ID: 1533580
    [Abstract] [Full Text] [Related]

  • 4. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [Abstract] [Full Text] [Related]

  • 5. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry.
    Vora JP, Burch A, Peters JR, Owens DR.
    Diabetes Care; 1992 Nov; 15(11):1484-93. PubMed ID: 1334825
    [Abstract] [Full Text] [Related]

  • 6. Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry.
    Vora JP, Burch A, Peters JR, Owens DR.
    Diabet Med; 1993 Oct; 10(8):736-43. PubMed ID: 8261756
    [Abstract] [Full Text] [Related]

  • 7. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, Bolli GB.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [Abstract] [Full Text] [Related]

  • 8. Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections.
    Hanas SR, Carlsson S, Frid A, Ludvigsson J.
    Diabetes Care; 1997 Apr; 20(4):487-90. PubMed ID: 9096966
    [Abstract] [Full Text] [Related]

  • 9. Influence of circulating epinephrine on absorption of subcutaneously injected insulin.
    Fernqvist E, Gunnarsson R, Linde B.
    Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
    Hollenbeck CB, Chen YD, Reaven GM.
    Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The variability of the absorption of subcutaneously injected insulin: effect of injection technique and relation with brittleness.
    de Meijer PH, Lutterman JA, van Lier HJ, van't Laar A.
    Diabet Med; 1990 Jul; 7(6):499-505. PubMed ID: 2142052
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Cavalot F, Trovati M.
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [Abstract] [Full Text] [Related]

  • 18. Alterations in glucose metabolism in the elderly patient with diabetes.
    Meneilly GS, Dawson K, Tessier D.
    Diabetes Care; 1993 Sep; 16(9):1241-8. PubMed ID: 8404427
    [Abstract] [Full Text] [Related]

  • 19. [Body fat distribution and blood pressure according to anthropometric change in Korean patients with non-insulin dependent diabetes mellitus (NIDDM)].
    Park HJ, Kim S, Kim EJ.
    Taehan Kanho Hakhoe Chi; 2006 Aug; 36(5):837-44. PubMed ID: 16953141
    [Abstract] [Full Text] [Related]

  • 20. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.